Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Correta Trial (Corticosteroid Reduction with Tacrolimus): prospective Brazilian multicenter, randomized trial of early corticosteroid reduction versus regular corticosteroid dosage maintenance on a tacrolimus [Prograf] and mycophenolate mofetil [Cellcept] immunosuppression regimen kidney transplant recipients,

Trial Profile

Correta Trial (Corticosteroid Reduction with Tacrolimus): prospective Brazilian multicenter, randomized trial of early corticosteroid reduction versus regular corticosteroid dosage maintenance on a tacrolimus [Prograf] and mycophenolate mofetil [Cellcept] immunosuppression regimen kidney transplant recipients,

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Jan 2010

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Tacrolimus (Primary) ; Prednisone
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Acronyms CORRETA

Most Recent Events

  • 21 Jan 2010 Results published in Clinical Transplantation.
  • 14 Nov 2007 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top